A detailed history of Andra Ap Fonden transactions in Exact Sciences Corp stock. As of the latest transaction made, Andra Ap Fonden holds 3,651 shares of EXAS stock, worth $206,281. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,651
Previous 81,800 95.54%
Holding current value
$206,281
Previous $3.46 Million 92.82%
% of portfolio
0.0%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$42.43 - $70.83 $3.32 Million - $5.54 Million
-78,149 Reduced 95.54%
3,651 $248,000
Q2 2024

Aug 07, 2024

SELL
$41.33 - $74.26 $2.23 Million - $4.01 Million
-54,000 Reduced 39.76%
81,800 $3.46 Million
Q1 2024

May 13, 2024

SELL
$56.27 - $73.77 $2.53 Million - $3.32 Million
-45,000 Reduced 24.89%
135,800 $9.38 Million
Q4 2023

Feb 15, 2024

BUY
$59.06 - $75.72 $437,044 - $560,328
7,400 Added 4.27%
180,800 $13.4 Million
Q3 2023

Nov 09, 2023

BUY
$65.94 - $99.04 $1.42 Million - $2.14 Million
21,600 Added 14.23%
173,400 $11.8 Million
Q2 2023

Aug 09, 2023

BUY
$62.68 - $95.05 $426,224 - $646,340
6,800 Added 4.69%
151,800 $14.3 Million
Q1 2023

May 12, 2023

BUY
$47.19 - $70.77 $3.5 Million - $5.24 Million
74,100 Added 104.51%
145,000 $9.83 Million
Q4 2022

Feb 13, 2023

SELL
$30.35 - $53.15 $361,165 - $632,485
-11,900 Reduced 14.37%
70,900 $3.51 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $399,625 - $617,125
12,500 Added 17.78%
82,800 $2.69 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $1.22 Million - $2.61 Million
34,200 Added 94.74%
70,300 $2.77 Million
Q4 2021

Feb 15, 2022

SELL
$72.5 - $100.68 $21,750 - $30,204
-300 Reduced 0.82%
36,100 $2.81 Million
Q3 2021

Nov 12, 2021

SELL
$90.24 - $124.05 $406,080 - $558,225
-4,500 Reduced 11.0%
36,400 $3.47 Million
Q2 2021

Aug 16, 2021

BUY
$93.66 - $139.27 $955,332 - $1.42 Million
10,200 Added 33.22%
40,900 $5.08 Million
Q1 2021

May 17, 2021

BUY
$116.57 - $155.01 $1.71 Million - $2.28 Million
14,700 Added 91.88%
30,700 $4.05 Million
Q4 2020

Feb 12, 2021

BUY
$99.61 - $142.12 $1.59 Million - $2.27 Million
16,000 New
16,000 $2.12 Million
Q2 2020

Aug 06, 2020

SELL
$55.75 - $92.75 $1.85 Million - $3.07 Million
-33,100 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$37.9 - $104.44 $333,520 - $919,072
8,800 Added 36.21%
33,100 $1.92 Million
Q4 2019

Feb 10, 2020

BUY
$77.66 - $99.74 $489,258 - $628,362
6,300 Added 35.0%
24,300 $2.25 Million
Q3 2019

Nov 19, 2019

BUY
$90.37 - $122.49 $243,999 - $330,723
2,700 Added 17.65%
18,000 $1.63 Million
Q2 2019

Aug 15, 2019

BUY
$89.51 - $118.04 $1.37 Million - $1.81 Million
15,300 New
15,300 $1.81 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Andra Ap Fonden Portfolio

Follow Andra Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.